AMS is the leading innovator in developing minimally invasive treatment options for enlarged prostate or BPH (benign prostatic hyperplasia). We help physicians cover the complete spectrum of solutions for patients suffering from enlarged prostate, from mildly symptomatic to severely obstructed.
600087-01A (12/07) |